Literature DB >> 1373641

Immunocytochemical determination of estrogen and progesterone receptors in human endometrial adenocarcinoma cells (Ishikawa cells).

H Hata1, H Kuramoto.   

Abstract

The regulation of both estrogen and progesterone receptor levels in human endometrial adenocarcinoma cells of the Ishikawa line was investigated immunocytochemically by using monoclonal antibodies. Positive staining for estrogen and progesterone receptors was observed in the nuclei of Ishikawa cells. Intercellular heterogeneity in receptor content was evident from the presence of receptor-positive or -negative cells and from differences in staining intensity of positive cells. Quantitative analysis was performed by scoring the staining intensity and the proportion of positively stained cells. The time and dose-dependent stimulatory effect of estradiol added to culture media on progesterone receptor levels was studied by applying both immunocytochemical and biochemical methods. Estradiol at 10 nM (optimal concentration) increased the intensity score for PR from an initial value of 10.1 to 78.3 after 72 h incubation, and the proportion of the positive staining cells from 6.7 to 42.7%. Promegestone (R5020) was effective at 1 microM concentration in decreasing the intensity score for ER from 31.1 to 14.6 after 72 h exposure and the proportion of positive cells from 19.0 to 11.4%.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1373641     DOI: 10.1016/0960-0760(92)90029-i

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  8 in total

1.  A novel role for the AAA ATPase spastin as a HOXA10 transcriptional corepressor in Ishikawa endometrial cells.

Authors:  Gaurang S Daftary; Amy M Tetrault; Elisa M Jorgensen; Jennifer Sarno; Hugh S Taylor
Journal:  Mol Endocrinol       Date:  2011-07-14

2.  HOXA10 regulates endometrial GABAA {pi} receptor expression and membrane translocation.

Authors:  Homayoun Sadeghi; Hugh S Taylor
Journal:  Am J Physiol Endocrinol Metab       Date:  2010-01-26       Impact factor: 4.310

3.  Regulation of vascular endothelial growth factor (VEGF) gene transcription by estrogen receptors alpha and beta.

Authors:  M D Mueller; J L Vigne; A Minchenko; D I Lebovic; D C Leitman; R N Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

4.  In vivo and in vitro estrogenic and progestagenic actions of Tibolone.

Authors:  Anil Sadarangani; Ana María Salgado; Sumie Kato; Mauricio Pinto; Andrés Carvajal; Carolina Monso; Gareth I Owen; Pilar Vigil
Journal:  Biol Res       Date:  2005       Impact factor: 5.612

Review 5.  HEC-1 cells.

Authors:  Hiroyuki Kurarmoto; Mieko Hamano; Manami Imai
Journal:  Hum Cell       Date:  2002-06       Impact factor: 4.174

6.  Enhanced estrogen-induced proliferation in obese rat endometrium.

Authors:  Qian Zhang; Qi Shen; Joseph Celestino; Michael R Milam; Shannon N Westin; Robin A Lacour; Larissa A Meyer; Gregory L Shipley; Peter J A Davies; Lei Deng; Adrienne S McCampbell; Russell R Broaddus; Karen H Lu
Journal:  Am J Obstet Gynecol       Date:  2009-02       Impact factor: 8.661

7.  The mechanism of action of the histone deacetylase inhibitor vorinostat involves interaction with the insulin-like growth factor signaling pathway.

Authors:  Rive Sarfstein; Ilan Bruchim; Ami Fishman; Haim Werner
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

8.  Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women.

Authors:  Bruce A Lessey; Wilder A Palomino; K B C Apparao; Steven L Young; Ruth A Lininger
Journal:  Reprod Biol Endocrinol       Date:  2006       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.